期刊文献+

抗结核杆菌人源噬菌体单链抗体库的构建及筛选 被引量:1

Construction and Screening of Human Single-chain Antibody Library of Anti-Mycobacterium Smegmatis
下载PDF
导出
摘要 目的:构建人源噬菌体展示单链抗体(ScFv)库,筛选抗结核杆菌特异性、高亲和力的ScFv.方法:从结核患者的外周血淋巴细胞中,提取RNA并通过RT-PCR扩增出VH和VL基因,并采用SOE-PCR构建ScFv基因,将其克隆入噬粒载pCANTAB5E中,转化于大肠杆菌TG1,通过辅助噬菌体M13K07援救构建噬菌体单链抗体库.结果:初级库库容量为3.5×106,在大肠杆菌TG1中重组后得到2.6×106的次级抗体库.结论:成功构建噬菌体展示ScFv库并获得人源抗结核杆菌特异性ScFv,为进一步研制抗抗结核杆菌的高特异性、高亲和力的基因工程抗体奠定了基础. Aim: To construct a human phage-displayed single-chain Fv antibody(ScFv) library and screen specific ScFv against Mycobacterium Smegmatis.Methods: The total RNA was extracted from peripheral blood lymphocytes in patients with Mycobacterium Smegmatis,first strand cDNA synthesis was performed using a cDNA synthesis kit and an oligo(dT)-18 primer.To human immunoglobulin H chain and L chain variable region of degenerate primers,cDNA first strand as a template,were amplified H chain and L chain variable region genes.SOE-PCR method to VH and VL fragments were assembled into ScFv fragments and then cloned into pCANTAB5E ScFv vector and transformed into competent TG 1 electric bacteria by helper phage rescue M13K07 get Mycobacterium Smegmatis single chain antibody phage display library.Results: A primary library of 3.5×106 and a second library of 2.6×106 were constructed.Conclusion: The results lay a solid foundation for preparation of human engineering antibody to Mycobacterium Smegmatis reported herein with higher affinity.
出处 《湖南师范大学自然科学学报》 CAS 北大核心 2011年第5期70-74,共5页 Journal of Natural Science of Hunan Normal University
基金 贵州省2011年社会发展科技攻关资助项目(黔科合SY字(2011)3020)
关键词 结核杆菌 人源噬菌体单链抗体 制备及筛选 Mycobacterium Smegmatis human single-chain antibody construction and screening
  • 相关文献

参考文献21

  • 1吴虢东,王玲.抗结核中药的研究进展[J].医学综述,2007,13(6):475-477. 被引量:28
  • 2李菁,林彤,宋帅,高闪电,邵军军,丛国政,独军政,常惠芸.基因工程抗体研究进展[J].生物技术通报,2009,25(10):40-44. 被引量:20
  • 3路艳,韩跃武,韩亚萍,刘玲玲,王春霞,李真真.抗白念珠菌人源性单链抗体库的构建及筛选[J].中国生物制品学杂志,2009,22(11):1063-1067. 被引量:4
  • 4HUSTON J S, LEVINSON D, MUDGET-HUNTER M, et al. Protein engineering of antibody binding sites : recovery of specifi- cactivity in an anti-digoxin single-chain Fv analogue produced in Escherichia coil[J]. Porc Natl Acad Sci USA,1988, 85(16) : 5879-5883.
  • 5WHITLOW M, BELL B A, FENG S L, et al. An improved linker for single-chain Fv with reduced aggregation and enhanced proteolytic stability[ J ]. Protein Eng, 1993,6 (8) :989-995.
  • 6BETYERr M, CHANG C P, ROBINSON R, et al. Escherichia coil secretion of an active chimeric antibody fragment [ J ]. Sci- ence, 1988, 240 ( 4855 ) : 1041-1043.
  • 7WINTER G. Synthetic human antibodies and a strategy for protein engineering[ J ]. FEBS Lett, 1998, 430: 92-94.
  • 8SHAHEEN F, DUAN L, ZHU M, et al. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle [ J ]. J Virol, 1996, 70 (6) :3392- 3400.
  • 9ANN C, COLLIER M, ROBERT W, et al. Treatment of human immunodeficiency virus infection with saquinavir, zidovudine, and zaleitabine[ J]. New Engl J Med, 1996, 334(16) :1011-1077.
  • 10FINNERN R, BYE J M, DOLMAN K M, et al. Molecular characteristics of anti-self antibody fragments against neutrophil cy- toplasmic antigens from human V gene phage display libraries [ J]. Clin Exp Immunol, 1995, 102 (3):566-574.

二级参考文献50

共引文献111

同被引文献3

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部